Literature DB >> 29656759

Physical behavior and associations with health outcomes in operable NSCLC patients: A prospective study.

J G Josien Timmerman1, M G H Marit Dekker-van Weering2, M W J M Michel Wouters3, M M Martijn Stuiver4, W Wanda de Kanter5, M M R Miriam Vollenbroek-Hutten6.   

Abstract

OBJECTIVES: Our objectives were to 1) characterize daily physical behavior of operable non-small cell lung cancer (NSCLC) patients, from preoperative to six months postoperative using accelerometry, and explore if physical behavior preoperative or one month postoperative is associated with better health outcomes at six months postoperative.
METHODS: A prospective study with 23 patients (13 female) diagnosed with primary NSCLC and scheduled for curative lung resection was performed. Outcome measures were assessed two weeks preoperative, and one, three and six months postoperative, and included accelerometer-derived physical behavior measures and the following health outcomes: six minute walking distance (6MWD), questionnaires concerning health-related quality of life (HRQOL), fatigue and distress.
RESULTS: On group average, physical behavior showed significant changes over time. Physical behavior worsened following surgery, but improved between one and six months postoperative, almost reaching preoperative levels. However, physical behavior showed high variability between patients in both amount as well as change over time. More time in moderate-to-vigorous physical activity in bouts of 10 min or longer in the first month postoperative was significantly associated with better 6MWD, HRQOL, distress, and fatigue at six months postoperative.
CONCLUSION: As expected, curative lung resection impacts physical behavior. Patients who were more active in the first month following surgery reported better health outcome six months postoperative. The large variability in activity patterns over time observed between patients, suggests that physical behavior 'profiling' through detailed monitoring of physical behavior could facilitate tailored goal setting in interventions that target change in physical behavior.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accelerometry; Lung cancer; Lung resection; Physical behavior; Quality of life; Sedentary behavior

Mesh:

Year:  2018        PMID: 29656759     DOI: 10.1016/j.lungcan.2018.03.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Toru Nakamichi; Yuki Uchiyama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2019-02-20       Impact factor: 3.603

Review 2.  Physical activity in surgical lung cancer patients: a systematic review.

Authors:  Weijiao Zhou; Katelyn E Webster; Ellen Lavoie Smith; Weiyun Chen; Philip T Veliz; Rishindra M Reddy; Janet L Larson
Journal:  Support Care Cancer       Date:  2022-04-06       Impact factor: 3.603

3.  Self-monitoring of Physical Activity After Hospital Discharge in Patients Who Have Undergone Gastrointestinal or Lung Cancer Surgery: Mixed Methods Feasibility Study.

Authors:  Marijke Elizabeth de Leeuwerk; Martine Botjes; Vincent van Vliet; Edwin Geleijn; Vincent de Groot; Erwin van Wegen; Marike van der Schaaf; Jurriaan Tuynman; Chris Dickhoff; Marike van der Leeden
Journal:  JMIR Cancer       Date:  2022-06-24

Review 4.  Association between physical activity and patient-reported outcome measures in patients with lung cancer: a systematic review and meta-analysis.

Authors:  Peña-Perez Teba; Mur-Gimeno Esther; Sebio-García Raquel
Journal:  Qual Life Res       Date:  2022-01-21       Impact factor: 4.147

5.  Physical Activity Levels Are Low in Inoperable Lung Cancer: Exploratory Analyses from a Randomised Controlled Trial.

Authors:  Lara Edbrooke; Catherine L Granger; Ross A Clark; Linda Denehy
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.